Article Information
History
- October 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Yongjun Sui1,*,
- Jianping Li1,
- Hanne Andersen2,
- Roushu Zhang3,
- Sunaina Kiran Prabhu3,
- Tanya Hoang1,
- David Venzon4,
- Anthony Cook2,
- Renita Brown2,
- Elyse Teow2,
- Jason Velasco2,
- Laurent Pessaint2,
- Ian N. Moore5,
- Laurel Lagenaur1,
- Jim Talton6,
- Matthew W. Breed7,
- Josh Kramer7,
- Kevin W. Bock5,
- Mahnaz Minai5,
- Bianca M. Nagata5,
- Hyoyoung Choo-Wosoba4,
- Mark G. Lewis2,
- Lai-Xi Wang3 and
- Jay A. Berzofsky1,*
- 1Vaccine Branch, Center of for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892
- 4Biostatistics and Data Management Section, Center of for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892
- 2BIOQUAL Inc., Rockville, MD 20850
- 3Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742
- 5Infectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases, Rockville, MD 20852
- 6Alchem Laboratories, Alachua, FL 32615
- 7Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Bethesda, MD 20892
- ↵*Correspondence to: Yongjun Sui, Vaccine Branch, National Cancer Institute, National Institutes of Health, 41 Medlars Drive, Bethesda, MD 20892 USA, Ph: 240-760-6726, Email: suiy{at}mail.nih.gov; Jay A. Berzofsky, Vaccine Branch, National Cancer Institute, National Institutes of Health, 41 Medlars Drive, Bethesda, MD 20892 USA, Ph: 240-760-6148, Email: berzofsj{at}mail.nih.gov